| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
40,447 |
36,200 |
$1.89M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
23,733 |
22,856 |
$621K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,838 |
8,270 |
$602K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,666 |
4,606 |
$376K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,173 |
4,100 |
$342K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,294 |
3,240 |
$288K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,668 |
3,499 |
$268K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
9,515 |
9,277 |
$143K |
| 92587 |
|
6,555 |
6,337 |
$110K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,541 |
2,378 |
$91K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,373 |
3,572 |
$81K |
| 90461 |
|
5,152 |
4,927 |
$73K |
| 90651 |
|
849 |
766 |
$63K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,572 |
5,119 |
$46K |
| 92558 |
|
5,717 |
5,592 |
$36K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,287 |
1,237 |
$35K |
| 90734 |
|
498 |
470 |
$21K |
| 90677 |
|
163 |
163 |
$19K |
| 90686 |
|
4,350 |
4,165 |
$18K |
| 90620 |
|
305 |
265 |
$14K |
| 0071A |
|
343 |
333 |
$13K |
| 99177 |
|
5,076 |
4,989 |
$13K |
| 90716 |
|
597 |
541 |
$13K |
| 90670 |
|
754 |
701 |
$13K |
| 0072A |
|
288 |
280 |
$11K |
| 3008F |
|
9,757 |
9,282 |
$11K |
| 90674 |
|
469 |
460 |
$9K |
| 99174 |
|
2,532 |
2,405 |
$9K |
| 92551 |
|
1,148 |
1,107 |
$7K |
| 90661 |
|
670 |
652 |
$7K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
250 |
231 |
$7K |
| 90700 |
|
1,874 |
1,758 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
396 |
386 |
$6K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
72 |
65 |
$6K |
| 90688 |
|
343 |
343 |
$5K |
| 90707 |
|
463 |
416 |
$5K |
| 96127 |
|
1,716 |
1,639 |
$5K |
| 0001A |
|
127 |
126 |
$5K |
| 90713 |
|
1,329 |
1,237 |
$5K |
| 90633 |
|
694 |
645 |
$4K |
| 0002A |
|
105 |
105 |
$4K |
| 90715 |
|
329 |
288 |
$4K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
50 |
50 |
$3K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
19 |
18 |
$2K |
| 99173 |
|
779 |
770 |
$2K |
| 90680 |
|
162 |
157 |
$1K |
| 90648 |
|
993 |
929 |
$1K |
| 90671 |
|
12 |
12 |
$1K |
| 90656 |
|
229 |
229 |
$1K |
| 90685 |
|
38 |
38 |
$622.19 |
| 0081A |
|
23 |
17 |
$560.00 |
| 90744 |
|
204 |
193 |
$528.36 |
| 0004A |
|
13 |
13 |
$520.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
29 |
29 |
$338.72 |
| 99051 |
|
334 |
327 |
$332.04 |
| 92015 |
Determination of refractive state |
16 |
16 |
$240.88 |
| 87807 |
|
28 |
28 |
$216.86 |
| 36416 |
|
227 |
224 |
$138.60 |
| 91307 |
|
579 |
521 |
$111.00 |
| 91300 |
|
229 |
210 |
$30.00 |
| 99050 |
|
12 |
12 |
$28.26 |
| 91308 |
|
27 |
19 |
$5.00 |
| 99072 |
|
2,524 |
2,411 |
$0.00 |
| 91305 |
|
42 |
32 |
$0.00 |